Work

Supplementary Figure 1-2 from CT Perfusion as an Early Biomarker of Treatment Efficacy in Advanced Ovarian Cancer: An ACRIN and GOG Study

Year: 2023

Type: supplementary-materials

Abstract: Figure S1. ACRIN 6695 plus RECIST CT scan schema; Figure S2. Kaplan-Meier PFS curve for patients who received bevacizumab and had increase vs. decrease in BF from T0 to T2.

DOI: 10.1158/1078-0432.22466643

Authors: Chaan S. Ng, Zheng Zhang, Susanna I. Lee, Helga S. Marques, Kyle Burgers, Feng Su, Joseph Bauza, Robert S. Mannel, Joan L. Walker, Warner King Huh, Stephen C. Rubin, Paul DiSilvestro, Lainie P. Martin, John K. Chan, Michael A. Bookman, Robert L. Coleman, Ting-Yim Lee

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361886482

Cites:

Cited by:

Related to: 10